The company chalks up a financial impact of about 150 billion Korean won ($102 million) from “preemptive production adjustments” made to mitigate potential manufacturing impacts, a spokesperson said.
CDMO Samsung Biologics estimates $102M impact stemming from ongoing union strike
Latest from Blog
Adia clears ethics review for CKD stem cell trial, recruitment next
The planned trial targets adults with Stage 2-4 chronic kidney disease and will track kidney function and inflammation markers. Recruitment starts after listing. Post Views: 0
Prenatal supplement and nutrition education gains momentum
Clinicians seek science-based prenatal nutrition insights to improve maternal and infant health outcomes Post Views: 0
Nutrition meets pharma: TopGum acquires PLD to expand US gummy manufacturing
Gummy dietary supplement provider TopGum has completed its acquisition of pharmaceuticals company P&L Developments’ (PLD) gummy manufacturing operations for US$35 million. The transaction was first announced in January this year and extends TopGum’s
‘How I ran a sub-4 debut marathon – with a simple fuelling strategy that actually worked’
Using glucose data, I fine-tuned my fuelling to avoid crashes and stay strong through 26.2 miles Post Views: 0
Yemen Joint Monitoring Report: Bimonthly Update on Food and Nutrition Security Crisis Risks (April 2026, No.14)
in English on Yemen; published on 5 May 2026 by ACAPS, FAO and 5count other organizations Post Views: 0